| Title : Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer's Disease - Stanciu_2023_Pharmaceuticals.(Basel)_16_ |
| Author(s) : Stanciu GD , Ababei DC , Solcan C , Bild V , Ciobica A , Beschea Chiriac SI , Ciobanu LM , Tamba BI |
| Ref : Pharmaceuticals (Basel) , 16 : , 2023 |
| Abstract : Stanciu_2023_Pharmaceuticals.(Basel)_16_ |
| ESTHER : Stanciu_2023_Pharmaceuticals.(Basel)_16_ |
| PubMedSearch : Stanciu_2023_Pharmaceuticals.(Basel)_16_ |
| PubMedID: 38004485 |
Stanciu GD, Ababei DC, Solcan C, Bild V, Ciobica A, Beschea Chiriac SI, Ciobanu LM, Tamba BI (2023)
Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer's Disease
Pharmaceuticals (Basel)
16 :
Stanciu GD, Ababei DC, Solcan C, Bild V, Ciobica A, Beschea Chiriac SI, Ciobanu LM, Tamba BI (2023)
Pharmaceuticals (Basel)
16 :